157 related articles for article (PubMed ID: 18490918)
21. The adenovirus E1A protein targets the SAGA but not the ADA transcriptional regulatory complex through multiple independent domains.
Shuen M; Avvakumov N; Walfish PG; Brandl CJ; Mymryk JS
J Biol Chem; 2002 Aug; 277(34):30844-51. PubMed ID: 12070146
[TBL] [Abstract][Full Text] [Related]
22. NSM00158 Specifically Disrupts the CtBP2-p300 Interaction to Reverse CtBP2-Mediated Transrepression and Prevent the Occurrence of Nonunion.
Chen X; Zhang W; Zhang Q; Song T; Yu Z; Li Z; Duan N; Dang X
Mol Cells; 2020 Jun; 43(6):517-529. PubMed ID: 32434298
[TBL] [Abstract][Full Text] [Related]
23. Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.
Parker SF; Felzien LK; Perkins ND; Imperiale MJ; Nabel GJ
J Virol; 1997 Mar; 71(3):2004-12. PubMed ID: 9032332
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus E1A proteins regulate phosphoenolpyruvate carboxykinase gene transcription through multiple mechanisms.
Klemm DJ; Colton LA; Ryan S; Routes JM
J Biol Chem; 1996 Apr; 271(14):8082-8. PubMed ID: 8626493
[TBL] [Abstract][Full Text] [Related]
25. Assembly of human C-terminal binding protein (CtBP) into tetramers.
Bellesis AG; Jecrois AM; Hayes JA; Schiffer CA; Royer WE
J Biol Chem; 2018 Jun; 293(23):9101-9112. PubMed ID: 29700119
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional control by adenovirus E1A conserved region 3 via p300/CBP.
Pelka P; Ablack JN; Torchia J; Turnell AS; Grand RJ; Mymryk JS
Nucleic Acids Res; 2009 Mar; 37(4):1095-106. PubMed ID: 19129215
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus E1A inhibits cardiac myocyte-specific gene expression through its amino terminus.
Bishopric NH; Zeng GQ; Sato B; Webster KA
J Biol Chem; 1997 Aug; 272(33):20584-94. PubMed ID: 9252373
[TBL] [Abstract][Full Text] [Related]
28. The carboxy-terminal region of adenovirus E1A activates transcription through targeting of a C-terminal binding protein-histone deacetylase complex.
Sundqvist A; Sollerbrant K; Svensson C
FEBS Lett; 1998 Jun; 429(2):183-8. PubMed ID: 9650586
[TBL] [Abstract][Full Text] [Related]
29. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
[TBL] [Abstract][Full Text] [Related]
30. p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing.
Flinterman MB; Mymryk JS; Klanrit P; Yousef AF; Lowe SW; Caldas C; Gäken J; Farzaneh F; Tavassoli M
Oncogene; 2007 Oct; 26(48):6863-74. PubMed ID: 17486071
[TBL] [Abstract][Full Text] [Related]
31. A cellular repressor of E1A-stimulated genes that inhibits activation by E2F.
Veal E; Eisenstein M; Tseng ZH; Gill G
Mol Cell Biol; 1998 Sep; 18(9):5032-41. PubMed ID: 9710587
[TBL] [Abstract][Full Text] [Related]
32. Stabilization of C-terminal binding protein 2 by cellular inhibitor of apoptosis protein 1 via BIR domains without E3 ligase activity.
Seo TW; Lee YT; Lee JS; Yoo SJ
Biochem Biophys Res Commun; 2020 Sep; 530(2):440-447. PubMed ID: 32553630
[TBL] [Abstract][Full Text] [Related]
33. E1A physically interacts with RUNX3 and inhibits its transactivation activity.
Cha EJ; Oh BC; Wee HJ; Chi XZ; Goh YM; Lee KS; Ito Y; Bae SC
J Cell Biochem; 2008 Sep; 105(1):236-44. PubMed ID: 18570183
[TBL] [Abstract][Full Text] [Related]
34. The transcriptional co-activator proteins p300 and CBP stimulate adenovirus E1A conserved region 1 transactivation independent of a direct interaction.
Mannervik M; Akusjärvi G
FEBS Lett; 1997 Sep; 414(1):111-6. PubMed ID: 9305742
[TBL] [Abstract][Full Text] [Related]
35. The transcription-repression domain of the adenovirus E1A oncoprotein targets p300 at the promoter.
Green M; Panesar NK; Loewenstein PM
Oncogene; 2008 Jul; 27(32):4446-55. PubMed ID: 18408753
[TBL] [Abstract][Full Text] [Related]
36. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
Sandmöller A; Meents H; Arnold HH
Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
[TBL] [Abstract][Full Text] [Related]
37. C-terminal binding proteins: central players in development and disease.
Stankiewicz TR; Gray JJ; Winter AN; Linseman DA
Biomol Concepts; 2014 Dec; 5(6):489-511. PubMed ID: 25429601
[TBL] [Abstract][Full Text] [Related]
38. Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins.
Sang N; Giordano A
J Cell Physiol; 1997 Feb; 170(2):182-91. PubMed ID: 9009147
[TBL] [Abstract][Full Text] [Related]
39. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.
Datto MB; Hu PP; Kowalik TF; Yingling J; Wang XF
Mol Cell Biol; 1997 Apr; 17(4):2030-7. PubMed ID: 9121451
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional regulation by C-terminal binding proteins.
Chinnadurai G
Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
